Listed

Mettler Toledo International Inc/: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Jul 30, 2021 and accepted by EDGAR at Jul 30, 2021, 09:58 ET.

Share

Management's discussion and analysis

As filed, 34,260 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.

General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the full year ending December 31, 2021.

Changes in local currency exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.

COVID-19

The ongoing coronavirus ("COVID-19") pandemic has resulted in millions of confirmed cases throughout the world and in all countries where we conduct business. The outbreak caused many governments to implement stay-at-home orders, quarantines, and significant restrictions on travel. During the course of the ongoing pandemic, several governments implemented work restrictions that prohibited many employees from going to their customary work locations and that required these employees to work remotely when possible. These restrictions continue to change as the COVID-19 situation evolves in each country and region, considering local circumstances related to vaccine availability, population vaccination rates, and emerging variant strains of COVID-19.

The health and safety of our employees and business partners have been our highest priority throughout the COVID-19 pandemic, and we have implemented several preventative and protective measures. We have also continued to support our customers with their essential businesses such as life sciences, food manufacturing, chemicals (e.g., sanitizers, disinfectants, soaps, etc.), food retail, and transportation and logistics.

Our production and logistics facilities are currently operational, and our office-based employees continue to adhere to any applicable jurisdictional stay-at-home orders. Our supply chain is currently continuing with some interruption. We continue to closely monitor risks associated with our supply chain, including the availability of certain components, material shortages, supplier delays, potential transportation delays, and higher transportation and material costs, which could significantly adversely affect sales and/or profitability in future quarters. We also continue to leverage our digital and remote sales and service capabilities in certain geographies where necessary, while also meeting delivery requirements with our global supply chain. Our service organization also continues to provide on-site and remote customer support to facilitate uptime, productivity, and regulatory compliance.

COVID-19 presents several risks to our business as further described in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020. Uncertainties related to COVID-19 and the resulting impact to the global economy continue in most regions of the world and market conditions can change quickly. The longer-term effects on our business will be impacted by the global economy and any economic implications in different regions of the world.

Results of Operations – Consolidated

The following tables set forth certain items from our interim consolidated statements of operations for the three and six month periods ended June 30, 2021 and 2020 (amounts in thousands).

Three months ended June 30, 2021 (unaudited)% 2020 (unaudited)% Six months ended June 30, 2021 (unaudited)% 2020 (unaudited)%
Net sales $924,351 100.0 $690,673 100.0 $1,728,741 100.0 $1,339,835 100.0
Cost of sales 387,447 41.9 292,703 42.4 720,141 41.7 567,456 42.4
Gross profit 536,904 58.1 397,970 57.6 1,008,600 58.3 772,379 57.6
Research and development 42,603 4.6 31,193 4.5 81,875 4.7 65,580 4.9
Selling, general and administrative 239,045 25.9 190,134 27.5 460,797 26.7 388,878 29.0
Amortization 16,218 1.8 13,889 2.0 30,102 1.7 27,887 2.1
Interest expense 10,439 1.1 9,582 1.4 19,910 1.2 19,801 1.5
Restructuring charges 876 0.1 860 0.1 2,069 0.1 2,765 0.2
Other income, net (2,661) (0.3) (2,943) (0.4) (1,951) (0.1) (6,286) (0.5)
Earnings before taxes 230,384 24.9 155,255 22.5 415,798 24.0 273,754 20.4
Provision for taxes 45,621 4.9 28,693 4.2 81,372 4.7 49,077 3.7
Net earnings $184,763 20.0 $126,562 18.3 $334,426 19.3 $224,677 16.8

Net sales

Net sales were $924.4 million and $690.7 million for the three months ended June 30, 2021, and 2020, respectively, and $1.7 billion and $1.3 billion for the six months ended June 30, 2021 and 2020, respectively. This represents an increase of 34% and 29% in U.S. dollars for the three and six months ended June 30, 2021, respectively. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 27% and 23% for the three and six months ended June 30, 2021, respectively. Net sales benefited approximately 1% from the PendoTECH acquisition for the three and six months ended June 30, 2021. We experienced broad-based growth with robust customer demand in most businesses and regions and strong execution of our sales and marketing programs. Growth in China also continued to be particularly strong. However, uncertainty relating to COVID-19 continues and market conditions may change quickly.

Net sales by geographic destination for the three months ended June 30, 2021 in U.S. dollars increased 31% in the Americas, 34% in Europe, and 37% in Asia/Rest of World. In local currencies, our net sales by geographic destination increased 29% in the Americas, 23% in Europe, and 28% in Asia/Rest of World. Our net sales by geographic destination for the six months ended June 30, 2021 in U.S. dollars increased 23% in the Americas, 29% in Europe, and 37% in Asia/Rest of World. Net sales by geographic destination for the six months ended June 30, 2021 in local currencies increased 22% in the Americas, 18% in Europe, and 28% in Asia/Rest of World. Net sales in the Americas benefited approximately 2% and 1% from the PendoTECH acquisition for the three and six months ended June 30, 2021, respectively, and net sales in Europe benefited approximately 1% from the PendoTECH acquisition for the three months ended June 30, 2021. Net sales growth in Asia/Rest of World in local currency includes 35% and 39% growth in China during the three and six months ended June 30, 2021, respectively. A discussion of sales by operating segment is included below.

As described in Note 19 to our consolidated financial statements for the year ended December 31, 2020, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products increased 37% in U.S. dollars and 30% in local currencies for the three months ended June 30, 2021 and increased 33% in U.S. dollars and 27% in local currencies for the six months ended June 30, 2021, compared to the corresponding periods in 2020. Net sales of products benefited approximately 2% and 1% from the PendoTECH acquisition for the three and six months ended June 30, 2021, respectively. Service revenue (including spare parts) increased by 22% in U.S. dollars and 15% in local currencies for the three months ended June 30, 2021 and increased 17% in U.S. dollars and 10% in local currencies for the six months ended June 30, 2021, compared to the corresponding periods in 2020.

Net sales of our laboratory products and services, which represented approximately 55% of our total net sales, increased 41% in U.S. dollars and 35% in local currencies for the three months ended June 30, 2021, and increased 33% in U.S. dollars and 27% in local currencies for the six months ended June 30, 2021. The local currency increase in net sales of our laboratory-related products for the three and six months ended June 30, 2021 includes growth in most product categories, especially in pipettes. Net sales of our laboratory products also benefited approximately 3% and 1% from the PendoTECH acquisition for the three and six months ended June 30, 2021, respectively.

Net sales of our industrial products and services, which represented approximately 39% of our total net sales, increased 27% in U.S. dollars and 20% in local currencies for the three months ended June 30, 2021, and increased 25% in U.S. dollars and 19% in local currencies for the six months ended June 30, 2021. The local currency increase in net sales of our industrial-related products for the three and six months ended June 30, 2021 includes particularly strong growth in core industrial, especially in China.

Net sales in our food retailing products and services, which represented approximately 6% of our total net sales, increased 16% in U.S. dollars and 9% in local currencies for the three months ended June 30, 2021, and increased 18% in U.S. dollars and 11% in local currencies for the six months ended June 30, 2021. The local currency increase in food retailing for the three months ended June 30, 2021 is primarily due to improved project activity in Europe, offset in part by a decline in the Americas.

Gross profit

Gross profit as a percentage of net sales was 58.1% and 57.6% for the three months ended June 30, 2021 and 2020, respectively, and 58.3% and 57.6% for the six months ended June 30, 2021 and 2020, respectively.

Gross profit as a percentage of net sales for products was 60.1% and 59.6% for the three months ended June 30, 2021 and 2020, respectively, and 60.4% and 60.2% for the six months ended June 30, 2021 and 2020.

Gross profit as a percentage of net sales for services (including spare parts) was 50.3% and 50.7% for the three months ended June 30, 2021 and 2020, respectively, and 50.5% and 49.3% for the six months ended June 30, 2021 and 2020, respectively.

The increase in gross profit as a percentage of net sales for the three and six months ended June 30, 2021 primarily reflects increased sales volume and favorable price realization, partially offset by higher transportation and material costs and temporary savings in the prior year.

Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales was 4.6% and 4.5% for the three months ended June 30, 2021 and 2020, respectively, and was 4.7% and 4.9% for the six months ended June 30, 2021 and 2020, respectively. Research and development expenses increased 37% in U.S. dollars and 28% in local currencies for the three months ended June 30, 2021, and increased 25% in U.S. dollars and 17% in local currencies for the six months ended June 30, 2021, respectively, compared to the corresponding periods in 2020. The local currency increase primarily relates to increased project activity and temporary savings in the prior year.

Selling, general and administrative expenses as a percentage of net sales were 25.9% and 27.5% for the three months ended June 30, 2021 and 2020, respectively, and was 26.7% and 29.0% for the six months ended June 30, 2021 and 2020, respectively. Selling, general and administrative expenses increased 26% in U.S. dollars and 20% in local currencies for the three months ended June 30, 2021, and increased 18% in U.S. dollars and 13% in local currencies for the six months ended June 30, 2021. The local currency increase primarily includes higher cash incentive expense and temporary savings in the prior year.

Amortization expense was $16.2 million and $13.9 million for the three months ended June 30, 2021 and 2020, respectively, and $30.1 million and $27.9 million for the six months ended June 30, 2021 and 2020, respectively.

Interest expense was $10.4 million and $9.6 million for the three months ended June 30, 2021 and 2020, respectively, and $19.9 million and $19.8 million for the six months ended June 30, 2021 and 2020, respectively.

Other charges (income), net includes non-service pension costs (benefits), net (gains) losses from foreign currency transactions and hedging activities, interest income and other items. Non-service pension benefits was $2.5 million and $3.0 million for the three months ended June 30, 2021 and 2020, respectively, and $5.0 million and $5.9 million and for the six months ended June 30, 2021 and 2020, respectively. Other charges (income), net also included $2.8 million of acquisition costs for the six months ended June 30, 2021.

Our reported tax rate was 19.8% and 18.5% during the three months ended June 30, 2021 and 2020, respectively, and 19.6% and 17.9% during the six months ended June 30, 2021 and 2020, respectively. The provision for taxes is based upon using our projected annual effective tax rate of 19.5% and 20.5% before non-recurring discrete tax items for the periods ended June 30, 2021 and 2020, respectively. The difference between our projected annual effective tax rate and the reported tax rate is related to the timing of excess tax benefits associated with stock option exercises.

Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 19 to our consolidated financial statements for the year ended December 31, 2020.

U.S. Operations (amounts in thousands)

Three months ended June 30, Six months ended June 30,
2021 2020% 2021 2020%
Total net sales $361,817 $276,855 31% $670,561 $544,654 23%
Net sales to external customers $323,310 $249,340 30% $595,269 $490,750 21%
Segment profit $79,272 $52,581 51% $142,943 $97,519 47%

Total net sales increased 31% and 23% for the three and six months ended June 30, 2021, respectively, compared with the corresponding period in 2020. Net sales to external customers increased 30% and 21% for the six months ended June 30, 2021, respectively, compared with the corresponding period in 2020. Net sales to external customers for the three and six months ended June 30, 2021 includes very strong growth in laboratory products, especially pipettes, and core industrial. The results are partially offset by a decline in food retailing. Net sales to external customers in our U.S. Operations also benefited approximately 4% and 2% from the PendoTECH acquisition for the three and six months ended June 30, 2021, respectively.

Segment profit increased $26.7 million and $45.4 million for the three and six months ended June 30, 2021, respectively, compared to the corresponding periods in 2020. Segment profit during the three and six months ended June 30, 2021 includes higher net sales volume and benefits from our margin expansion, offset in part by higher transportation and material costs and temporary cost savings in the prior year.

Swiss Operations (amounts in thousands)

Three months ended June 30, 2021 2020 %1) Six months ended June 30, 2021 2020 %1)
Total net sales $242,018 $171,435 41% $465,764 $356,180 31%
Net sales to external customers $40,836 $28,948 41% $80,117 $60,844 32%
Segment profit $69,516 $48,248 44% $134,395 $102,158 32%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales increased 41% in U.S. dollars and 34% in local currency for the three months ended June 30, 2021, respectively, and increased 31% in U.S. dollars and 23% in local currency for the six months ended June 30, 2021 compared to the corresponding periods in 2020. Net sales to external customers increased 41% in U.S. dollars and 36% in local currency for the three months ended June 30, 2021 and increased 32% in U.S. dollars and 26% in local currency for the six months ended June 30, 2021, compared to the corresponding periods in 2020. The increase in local currency net sales to external customers for the three and six months ended June 30, 2021 includes includes strong growth in most product categories.

Segment profit increased $21.3 million and $32.2 million the three and six month periods ended June 30, 2021, compared to the corresponding periods in 2020. Segment profit during the three and six months ended June 30, 2021 includes higher net sales volume, benefits of our cost savings initiatives and favorable foreign currency translation, offset in part by higher transportation and material costs and temporary cost savings in the prior year.

Western European Operations (amounts in thousands)

Three months ended June 30, 2021 2020 %1) Six months ended June 30, 2021 2020 %1)
Total net sales $257,595 $188,750 36% $502,200 $383,789 31%
Net sales to external customers $201,722 $149,051 35% $394,072 $302,376 30%
Segment profit $38,476 $30,345 27% $76,342 $54,452 40%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales increased 36% in U.S. dollars and 24% in local currencies for the three months ended June 30, 2021 and increased 31% in U.S. dollars and 19% in local currencies for the six months ended June 30, 2021, compared to the corresponding periods in 2020. Net sales to external customers increased 35% in U.S. dollars and 23% in local currencies for the three months ended June 30, 2021, and increased 30% in U.S. dollars and 19% in local currencies for the six months ended June 30, 2021, compared to the corresponding periods in 2020. Net sales to external customers for the three and six months ended June 30, 2021 includes very strong growth in most product categories.

Segment profit increased $8.1 million and $21.9 million for the three and six month periods ended June 30, 2021, respectively, compared to the corresponding periods in 2020. Segment profit increased during the three and six months ended June 30, 2021 primarily due to higher net sales volume, benefits of our cost savings initiatives and favorable foreign currency translation, offset in part by higher transportation and material costs and temporary cost savings in the prior year.

Chinese Operations (amounts in thousands)

Three months ended June 30, 2021 2020 %1) Six months ended June 30, 2021 2020 %1)
Total net sales $278,050 $186,638 49% $503,202 $335,986 50%
Net sales to external customers $205,521 $140,907 46% $361,595 $241,506 50%
Segment profit $94,663 $63,955 48% $166,687 $109,505 52%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales increased 49% in U.S. dollars and 36% in local currency for the three months ended June 30, 2021 and increased 50% in U.S. dollars and 38% in local currency for the six months ended June 30, 2021, compared to the corresponding periods in 2020. Net sales to external customers increased 46% in U.S. dollars and 34% in local currency by origin for the three months ended June 30, 2021 and increased 50% in U.S. dollars and 38% in local currency during the six months ended June 30, 2021, compared to the corresponding periods in 2020. The increase in local currency net sales to external customers during the three and six months ended June 30, 2021 reflects particularly strong growth in both laboratory and industrial products. However, market conditions may change quickly and we will face more difficult prior period comparisons during the remainder of 2021.

Segment profit increased $30.7 million and $57.2 million for the three and six month periods ended June 30, 2021, respectively, compared to the corresponding periods in 2020. The increase in segment profit for the three and six months ended June 30, 2021 primarily reflects increased sales volume and favorable foreign currency translation, offset in part by higher transportation and material costs and temporary cost savings in the prior year.

Other (amounts in thousands)

Three months ended June 30, 2021 2020 %1) Six months ended June 30, 2021 2020 %1)
Total net sales $154,237 $123,302 25% $300,059 $246,130 22%
Net sales to external customers $152,962 $122,427 25% $297,688 $244,359 22%
Segment profit $21,414 $13,122 63% $41,586 $24,148 72%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales and net sales to external customers increased 25% and 22% in U.S. dollars for the three and six months ended June 30, 2021, respectively. Total net sales and net sales to external customers increased 17% in local currencies for the three months ended June 30, 2021, and increased 16% and 15%, respectively, in local currencies for the six months ended June 30, 2021, compared to the corresponding periods in 2020. The increase in net sales to external customers includes strong growth in most product categories.

Segment profit increased $8.3 million and $17.4 million for the three and six months ended June 30, 2021, respectively, compared to the corresponding periods in 2020. The increase in segment profit for the six months ended June 30, 2021 is primarily related to increased sales volume and favorable foreign currency translation.

Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash to meet our obligations and commitments. Sources of liquidity includes, cash flows from operating activities, available borrowings under our Credit Agreement, the ability to obtain appropriate financing and our cash and cash equivalent balances. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $404.4 million during the six months ended June 30, 2021, compared to $248.8 million in the corresponding period in 2020. The increase for the six months ended June 30, 2021 is primarily due to higher net earnings.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $47.4 million for the six months ended June 30, 2021 compared to $37.1 million in the corresponding period in 2020. We expect to make net investments in new or expanded manufacturing facilities of $10 million to $15 million over the next two years.

Senior Notes and Credit Facility Agreement

Our debt consisted of the following at June 30, 2021:

U.S. Dollar Other Principal Trading Currencies Total
3.67% $50 million ten-year Senior Notes due December 17, 2022 $50,000 $— $50,000
4.10% $50 million ten-year Senior Notes due September 19, 2023 50,000 — 50,000
3.84% $125 million ten-year Senior Notes due September 19, 2024 125,000 — 125,000
4.24% $125 million ten-year Senior Notes due June 25, 2025 125,000 — 125,000
3.91% $75 million ten-year Senior Notes due June 25, 2029 75,000 — 75,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035 50,000 — 50,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030 — 149,094 149,094
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034 — 161,021 161,021
1.06% Euro 125 million fifteen-year Senior Notes due March 19, 2036 — 149,094 149,094
Debt issuance costs, net (1,590) (1,631) (3,221)
Total Senior Notes 473,410 457,578 930,988
$1.25 billion Credit Agreement, interest at LIBOR plus 87.5 basis points 512,501 155,140 667,641
Other local arrangements 3,574 52,827 56,401
Total debt 989,485 665,545 1,655,030
Less: current portion (349) (52,676) (53,025)
Total long-term debt $989,136 $612,869 $1,602,005

On June 25, 2021, we entered into a $1.25 billion Credit Agreement ("the Credit Agreement"), which amended our $1.1 billion Amended and Restated Credit Agreement (the "Prior Credit Agreement"), that is further described in Note 8 of our consolidated financial statements.

In May 2021, we entered into an agreement to issue and sell $125 million twelve-year Senior Notes with a fixed interest rate of 2.83%. The Senior Notes will be issued in July 2021 and will mature July 2033. The terms of the Senior Notes are consistent with the previous Senior Notes as described above. We used the proceeds from the sale of the notes to refinance existing indebtedness and for other general corporate purposes.

As of June 30, 2021, approximately $576.3 million of additional borrowings was available under our Credit Agreement, and we maintained $142.3 million of cash and cash equivalents. During the six months ended June 30, 2021, the Company increased its long-term debt primarily due to the funding of the PendoTECH acquisition as described in Note 4. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates. Further, we do not have any downgrade triggers related to ratings from rating agencies that would accelerate the maturity dates of our debt.

We currently believe that cash flow from operating activities, together with liquidity available under our Credit Agreement and local working capital facilities and our cash balances, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for the foreseeable future.

In December 2020, the Company entered into an agreement to issue and sell EUR 125.0 million of 15-year 1.06% Euro Senior Notes ("1.06% Euro Senior Notes"). The terms of the Euro Senior Notes are consistent with the previous Euro Senior Notes as described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020. The Company also entered into a forward contract to receive $152.1 million at the time of issuing the 1.06% Euro Senior Notes in March 2021. The Company issued the 1.06% Euro Senior Notes with a fixed interest rate of 1.06% in March 2021. The 1.06% Euro Senior Notes are unsecured obligations of the Company and will mature on March 19, 2036. Interest on the 1.06% Euro Senior Notes is payable semi-annually in March and September of each year.

In April 2018, two of our non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of Swiss franc LIBOR plus 87.5 basis points. The loans were renewed for one year in April 2021.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. In March 2021, we acquired all the membership interests of Mayfair Technology, LLC, ("PendoTECH") a manufacturer and distributor of single-use sensors, transmitters, control systems and software for measuring, monitoring and data collection primarily in bioprocess applications. PendoTECH serves bio-pharmaceutical manufacturers and life science laboratories and is located in the United States. The initial cash payment was $185.0 million and we may be required to pay additional consideration of up to $20.0 million and other post-closing amounts. For additional information related to the PendoTECH acquisition refer to Note 4 to the interim consolidated financial statements.

Share Repurchase Program

In November 2020, the Company's Board of Directors authorized an additional $2.5 billion to be added to our share repurchase program, which has $2.6 billion of remaining availability as of June 30, 2021. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and existing cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors.

We have purchased 29.8 million shares since the inception of the program through June 30, 2021. During the six months ended June 30, 2021 and 2020, we spent $475.0 million and $200.0 million on the repurchase of 390,538 and 268,161 shares at an average price per share of $1,216.25 and $745.80, respectively. We also reissued 35,636 shares and 114,109 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the six months ended June 30, 2021 and 2020, respectively.

Effect of Currency on Results of Operations

Our earnings are affected by changes in exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, Chinese renminbi, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings decrease. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also decrease. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.8 million to $2.0 million annually.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese renminbi. The impact on our earnings before tax of the Chinese renminbi weakening 1% against the U.S. dollar is a reduction of approximately $2.1 million to $2.3 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at June 30, 2021, we estimate that a 5% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $35.1 million in the reported U.S. dollar value of our debt.

Forward-Looking Statements Disclaimer

You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth and long-term impacts of the COVID-19 pandemic. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue.”

We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, customer demand, our competitive position, pricing, our supply chain, adequacy of our facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, planned research and development efforts and product introductions, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of the COVID-19 pandemic on our businesses.

Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including the uncertain duration and severity of the COVID-19 pandemic. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2020 and other reports filed with the SEC from time to time.

Market risk

As filed, 173 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of June 30, 2021, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Controls and procedures

As filed, 703 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 208 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For the three and six months ended June 30, 2021 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$924.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-01-01 to 2021-06-30$1.73bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit3 months2021-04-01 to 2021-06-30$536.9mus-gaap:GrossProfit
Gross profit6 months2021-01-01 to 2021-06-30$1.01bnus-gaap:GrossProfit
Research and development3 months2021-04-01 to 2021-06-30$42.6mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$81.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-04-01 to 2021-06-30$239.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2021-01-01 to 2021-06-30$460.8mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2021-04-01 to 2021-06-30$10.4mus-gaap:InterestExpense
Interest expense6 months2021-01-01 to 2021-06-30$19.9mus-gaap:InterestExpense
Income tax3 months2021-04-01 to 2021-06-30$45.6mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2021-01-01 to 2021-06-30$81.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-04-01 to 2021-06-30$184.8mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30$334.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30$7.85us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30$14.17us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-04-01 to 2021-06-30$7.97us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-01-01 to 2021-06-30$14.37us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-04-01 to 2021-06-3023,521,793 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-01-01 to 2021-06-3023,603,805 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30$404.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$47.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2021-01-01 to 2021-06-30$475.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-06-30$142.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$1.17bnus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$3.14bnus-gaap:Assets
Current liabilitiesAt period end2021-06-30$938.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$2.95bnus-gaap:Liabilities
Long-term debtAt period end2021-06-30$1.60bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-06-30$53.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2021-06-30$191.4mus-gaap:StockholdersEquity
Shares outstandingAt period end2021-06-3023,116,939 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001037646-21-000039. Last ingested by Listed: Nov 13, 2026, 02:43 ET. Listed shows no prices and gives no investment advice.